Excelestar Ventures LLC

Excited to announce our founding partner Tasneem Dohadwala has won Startup Boston’s Investor of the Year! The award is a true testament to the success of the incredible founders and teams driving innovation in the startup community in Boston and beyond. Learn more about Tasneem and our mission here at Excelestar Ventures below: https://lnkd.in/eRn9sztP

This week on Achiiv’s Invisible Ink: The Founder Chronicles, our founding partner Tasneem Dohadwala sat down with Shubha K. Chakravarthy outlining the essential fundraising guide for first time founders. Tasneem provides helpful tips for founders navigating technically demanding industries like med-tech or cleantech. She also unpacks the rigorous diligence and strategic thinking that professional investors bring to every deal, highlighting the pivotal factors that tip the scales in your favor. Tune in to understand what it takes to bring groundbreaking medical devices to market: https://lnkd.in/gZ---6px

FDA issues final guidance on AI-enabled device updates. The FDA's new Predetermined Change Control Plan (PCCP) framework offers manufacturers a pathway to update AI-enabled medical devices postmarket without additional submissions. This regulatory milestone enables iterative improvements to device performance while maintaining safety and effectiveness. This breakthrough in regulation signals more flexibility for innovation in AI-driven healthcare solutions. For investors, it underscores growth potential in adaptive medical technologies that continuously evolve to improve outcomes. Learn more in Elise Reuter’s article for MedTech Dive: https://lnkd.in/giuSNyQY

A recent study supported by the The National Institutes of Health of Health Clinical Center highlights how AI-enabled image analysis is transforming medical diagnostics. Originally designed to catch one disease, tools like these are now revealing insights into others, such as cardiovascular disease and osteoporosis—paving the way for “opportunistic screening.” For investors, this demonstrates the untapped potential of AI in healthcare—streamlining diagnostics, improving outcomes, and addressing unmet needs in preventative care. It’s an opportunity to back technologies that not only innovate but also transform global health systems. Read more in Health Tech World: https://lnkd.in/eDdr_Fap 

Excited to announce our founding partner Tasneem Dohadwala will be speaking at The New England Venture Summit on December 11th at the Hilton in Boston Dedham, hosted by youngStartup Ventures! Tasneem will be speaking on the ‘Medtech Venture Outlook’ panel alongside Teri F. Willey of Pathway to Cures, Fiona Miller of quadraScope Ventures, Dr Laurent Metz MD MBA of Robin Hood Ventures, Bruce Cohen of Xeraya Capital and Andrew Clapp of Brightside Venture Partners. Join them as they dive into the nuances of building fundable ventures in the med-tech space, the transformative role of AI in therapeutics, and the qualities that make CEOs stand out to investors. Tasneem will also be a Featured Investor for the event. Learn more about the event here: https://lnkd.in/eEnZaDGJ [page break] #VentureSummit #VentureCapital

Are women over 50 uniquely equipped to succeed as entrepreneurs? Veteran entrepreneur Sheila Lirio Marcelo makes a compelling case. With decades of experience balancing careers, families, and life’s challenges, they bring unmatched resilience, empathy, and leadership to the table. This thought-provoking piece challenges the myths of ageism and redefines what it means to start fresh later in life. A must-read in Fast Company for anyone reconsidering their next chapter—or simply seeking a new perspective on entrepreneurship: https://lnkd.in/g9hN2xBW

Accessible AI tools like ChatGPT, Bubble, and GitHub Copilot are revolutionizing how startups go from idea to market. Founders now need less capital and fewer developers, focusing instead on creativity, strategy, and customer empathy to stand out. With lower costs and faster iteration, AI is democratizing entrepreneurship, opening doors for diverse founders to innovate and scale efficiently. Learn more about how AI is transforming startup launch strategies in Itay Sagie’s article for Inc. Magazine: https://lnkd.in/gMxCTzMR

AI-driven cardiac devices are transforming heart health with real-time monitoring and personalized therapy. The market for cardiovascular devices is projected to grow to $140 billion by 2033, reflecting the rapid adoption of AI-enhanced heart health solutions. With adaptive implants and wearable monitors, AI integrates monitoring and therapy for better outcomes and 24/7 care. These advances are paving the way for a new era in personalized medicine, providing precision care that evolves with the patient’s needs. Read more in Medical Device Network: https://lnkd.in/dBrdrAGJ

The potential for innovation knows no boundaries, yet systemic barriers continue to limit opportunities for many talented entrepreneurs. Samyr Laine’s insights highlight the urgent need for a more inclusive venture capital ecosystem—one that values diversity as a strength. By broadening networks, revising investment criteria, and fostering inclusivity, the VC industry can uncover transformative ideas and drive innovation while generating stronger returns. Read more about creating a truly equitable and innovative VC landscape in C-Suite Media / CSQ - Voice of the C-Suite: https://lnkd.in/e5jwMGDy

As the demand for smarter, AI-powered solutions grows, the rise of 'AI-as-a-service' is paving the way for cutting-edge healthcare innovations. With FDA-cleared devices that predict sepsis and detect skin cancers, the integration of AI and advanced manufacturing is enabling breakthroughs in personalized medicine and operational efficiency. Learn more about these advancements in Emily Newton’s article for Medical Product Outsourcing: https://lnkd.in/gHb6FEjm